Phase II study of personalized peptide vaccination for previously treated advanced colorectal cancer.
Kibe S, Yutani S, Motoyama S, Nomura T, Tanaka N, Kawahara A, Yamaguchi T, Matsueda S, Komatsu N, Miura M, Hinai Y, Hattori S, Yamada A, Kage M, Itoh K, Akagi Y, Sasada T.
Kibe S, et al. Among authors: akagi y.
Cancer Immunol Res. 2014 Dec;2(12):1154-62. doi: 10.1158/2326-6066.CIR-14-0035. Epub 2014 Oct 28.
Cancer Immunol Res. 2014.
PMID: 25351849
Clinical Trial.